About Novocuff
Novocuff is a company based in San Luis Obispo (United States) founded in 2021 by Amelia Degenkolb and Donald Lee. Novocuff has raised $28 million across 3 funding rounds from investors including March of Dimes, Laborie Medical and HHS. Novocuff offers products and services including Novocuff Cervical Control System. Novocuff operates in a competitive market with competitors including Materna Medical, NUA Surgical, CooperSurgical, Alydia Health and Clinical Innovations, among others.
- Headquarter San Luis Obispo, United States
- Founders Amelia Degenkolb, Donald Lee
- SectorsHealthcare
- Email••••••••
- Website novocuff.com
- Social LinkedIn X
- Legal Name Novocuff, Inc.
- Total Equity Funding$28M (USD)
in 3 rounds
- Latest Funding Round$26M (USD), Series A
Jun 2024
- InvestorsMarch of Dimes
& 6 more
Products & Services of Novocuff
Novocuff offers a comprehensive portfolio of products and services, including Novocuff Cervical Control System.
Supports cervix to retain amniotic fluid and prevent preterm birth in at-risk pregnancies.
Funding Insights of Novocuff
Novocuff has successfully raised a total of $28M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $26 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $28M
- Total Rounds 3
- Last Round Series A — $26M
- First Round $2M
(Jun 2021)
- Investors Count 7
All 3 funding rounds of Novocuff with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | $26M | Series A | – | AXA Investment Managers | |
| Aug 2023 | $295,605 | Grant | – | – | |
| Jun 2021 | $2M | Seed | – | Laerdal Million Lives Fund | – |
7 investors in total: 7 institutional.
Investors in Novocuff
Novocuff has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include March of Dimes, Laborie Medical and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in disruptive health technologies for life-saving impact. | – | laerdalmillionlives.com | - | |
Diversified alternative assets are managed through investment strategies. | 1994 | axa-im.com | Puteaux, France | |
Avestria Ventures is focused on funding women's health and life science ventures. | – | avestria.vc | San Francisco, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Medical products for female lower urinary tract dysfunctions are provided. | 1967 | laborie.com | Mississauga, Canada | |
A venture capital fund focused on women's health innovation. | – | rhcapital.vc | - | |
Provider of maternal and infant health support services. This organization supports research, education, and advocacy efforts to improve maternal and infant health outcomes. It offers resources and programs for families and healthcare professionals, including support for those experiencing pregnancy complications or loss. The organization also advocates for policies that prioritize the health of mothers and babies. Services include educational materials, community support networks, and funding for research initiatives. | 1938 | marchofdimes.org | United States |
Investor details for Novocuff
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Novocuff
2 people are tracked at Novocuff (2 in leadership).
| Name | Role | Group |
|---|---|---|
Amelia Degenkolb | Co-Founder & CEO | Leadership |
Donald Lee | Co-Founder & COO | Leadership |
Complete people profiles for Novocuff
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Novocuff
3 dated milestones of Novocuff across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Novocuff is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series A, of $26.0M.
Competitors of Novocuff
Novocuff operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Materna Medical, NUA Surgical, CooperSurgical, Alydia Health and Clinical Innovations, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| maternamedical.com | 2010 | Mountain View, United States | – | 8 | Provider of medical devices for women's pelvic health | |
| nuasurgical.com | 2018 | Galway, Ireland | $6.86M | – | Specialized surgical retractors are developed to improve C-Section safety. | |
| coopersurgical.com | 1990 | Trumbull, United States | – | – | Offers medical devices for fertility, contraception, and women's health care globally. | |
| alydiahealth.com | 2010 | Menlo Park, United States | $34.18M | 32 | Medical devices for postpartum hemorrhage treatment are developed. | |
| clinicalinnovations.com | 1993 | Murray, United States | – | 182 | Medical devices for mothers and their babies | |
| omeqmedical.com | 2011 | Ramat Gan, Israel | $700,000 | – | Sensor-based epidural placement system is developed for pain management injections. | |
| novatemedical.com | 2010 | New Orleans, United States | – | 1 | Obstetric device developed to prevent childbirth infections. |
Detailed competitors of Novocuff
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novocuff
Complete news archive for Novocuff
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Novocuff
10 companies that operate in the same segment as Novocuff (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 124.07 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 47 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Novocuff
Novocuff was founded in 2021.
Novocuff is headquartered in San Luis Obispo, United States. It is registered at San Luis Obispo, California, United States.
Amelia Degenkolb is the current CEO of Novocuff. They have also founded this company.
Novocuff is a funded company, having raised a total of $28M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Jun 2021.
Developer of medical device to prevent infant mortality caused by preterm birth complications. It offers Novocuff Cervical Control System (CCS) that stabilizes and closes the cervix to retain amniotic fluid and sustain cervical length to extend pregnancy.
Novocuff's top competitors include Materna Medical, Alydia Health and NUA Surgical.
Novocuff offers Novocuff Cervical Control System.
Novocuff has 7 investors. Key investors include March of Dimes, Laborie Medical, HHS, AXA Investment Managers, and Laerdal Million Lives Fund.
Novocuff operates through Novocuff, Inc..